InfiMed, Nikken to co-develop Infitropin

InfiMed Therapeutics ( Cambridge, Mass.) and Nikken Chemicals (Tokyo, Japan) will develop InfiMed's Infitropin CR controlled-release formulation of human growth hormone to treat children with growth h...